Platelet antiaggregants in stroke prevention.

Link to article at PubMed

Platelet antiaggregants in stroke prevention.

Neurol Clin. 2013 Aug;31(3):633-57

Authors: Morales Vidal SG, Ruland S

Antiplatelet agents are one of the main interventions for recurrent ischemic stroke prevention. Their time of use, dosage, and combination of therapy have different effects in terms of stroke risk reduction and adverse effects. This review provides an evidence-based update of the latest on antiplatelet therapy for stroke prevention.

PMID: 23896497 [PubMed - in process]

Leave a Reply

Your email address will not be published. Required fields are marked *